Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Preferred Shares (2017 - 2021)

Avalo Therapeutics (AVTX) has disclosed Preferred Shares for 4 consecutive years, with $1000.0 as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Preferred Shares fell 20.45% year-over-year to $1000.0, compared with a TTM value of $1000.0 through Mar 2021, down 20.45%, and an annual FY2020 reading of $1000.0, down 65.0% over the prior year.
  • Preferred Shares was $1000.0 for Q1 2021 at Avalo Therapeutics, roughly flat from $1000.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $2857.0 in Q4 2018 and bottomed at $1000.0 in Q4 2020.
  • Average Preferred Shares over 4 years is $2005.6, with a median of $2057.0 recorded in 2018.
  • The sharpest move saw Preferred Shares changed 0.0% in 2019, then plummeted 65.0% in 2020.
  • Year by year, Preferred Shares stood at $2857.0 in 2018, then changed by 0.0% to $2857.0 in 2019, then crashed by 65.0% to $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2021.
  • Business Quant data shows Preferred Shares for AVTX at $1000.0 in Q1 2021, $1000.0 in Q4 2020, and $1257.0 in Q3 2020.